REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,014,500 | -69.8% | 350,000 | -33.3% | 1.32% | -69.9% |
| Q2 2023 | $13,287,750 | +65.0% | 525,000 | +110.0% | 4.39% | +84.3% |
| Q1 2023 | $8,053,000 | +45.4% | 250,000 | -16.7% | 2.38% | +0.7% |
| Q4 2022 | $5,538,000 | -47.4% | 300,000 | -23.1% | 2.36% | -20.0% |
| Q3 2022 | $10,530,000 | +346.8% | 390,000 | +336.8% | 2.96% | +503.3% |
| Q2 2017 | $2,357,000 | -71.6% | 89,295 | -77.7% | 0.49% | -67.1% |
| Q1 2015 | $8,292,000 | +1119.4% | 400,000 | +1900.0% | 1.49% | +210.6% |
| Q2 2014 | $680,000 | +7.9% | 20,000 | 0.0% | 0.48% | +28.3% |
| Q1 2014 | $630,000 | – | 20,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |